These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25462418)

  • 1. Cognitive tolerability following successful long term treatment of major depression and anxiety disorders with SSRi antidepressants.
    Popovic D; Vieta E; Fornaro M; Perugi G
    J Affect Disord; 2015 Mar; 173():211-5. PubMed ID: 25462418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment effects on residual cognitive symptoms among partially or fully remitted patients with major depressive disorder: A randomized, double-blinded, exploratory study with vortioxetine.
    Nierenberg AA; Loft H; Olsen CK
    J Affect Disord; 2019 May; 250():35-42. PubMed ID: 30826492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of atypical antipsychotics in depressive syndromes].
    Quintin P; Thomas P
    Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Effects of Antidepressants with Different Mechanisms of Action on Efficacy, Cognitive Functions and Side Effects.
    Erdoğan Ç; Özdemir Rezaki H; Koçak OM; Buturak ŞV
    Turk Psikiyatri Derg; 2020; 31(2):90-98. PubMed ID: 32594496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VORTIOXETINE - THE NEW ANTIDEPRESSANT AGENT WITH PROCOGNITIVE PROPERTIES.
    Dziwota E; Olajossy M
    Acta Pol Pharm; 2016 Nov; 73(6):1433-1437. PubMed ID: 29634095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agomelatine versus other antidepressive agents for major depression.
    Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008851. PubMed ID: 24343836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study.
    Castellano S; Ventimiglia A; Salomone S; Ventimiglia A; De Vivo S; Signorelli MS; Bellelli E; Santagati M; Cantarella RA; Fazio E; Aguglia E; Drago F; Di Nuovo S; Caraci F
    CNS Neurol Disord Drug Targets; 2016; 15(10):1290-1298. PubMed ID: 27712575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and tolerability of dexmecamylamine (TC-5214) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to antidepressant therapy: results of a long-term study.
    Tummala R; Desai D; Szamosi J; Wilson E; Hosford D; Dunbar G; Eriksson H
    J Clin Psychopharmacol; 2015 Feb; 35(1):77-81. PubMed ID: 25514064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vortioxetine : a review of efficacy, safety and tolerability with a focus on cognitive symptoms in major depressive disorder.
    Al-Sukhni M; Maruschak NA; McIntyre RS
    Expert Opin Drug Saf; 2015 Aug; 14(8):1291-304. PubMed ID: 26022537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment.
    Fava M; Graves LM; Benazzi F; Scalia MJ; Iosifescu DV; Alpert JE; Papakostas GI
    J Clin Psychiatry; 2006 Nov; 67(11):1754-9. PubMed ID: 17196056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of short-term use of benzodiazepines on cognitive function of major depressive disorder patients being treated with antidepressants.
    Duan Y; Wei J; Geng W; Jiang J; Zhao X; Li T; Jiang Y; Shi L; Cao J; Zhu G; Zhang K; Yu X
    J Affect Disord; 2019 Sep; 256():1-7. PubMed ID: 31154087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Weston J; Singh J; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?
    Ribot R; Ouyang B; Kanner AM
    Epilepsy Behav; 2017 May; 70(Pt A):5-9. PubMed ID: 28407526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of cognitive impairment between medicated and medication-free patients with remitted major depression: class-specific influence by tricyclic antidepressants and newer antidepressants.
    Nagane A; Baba H; Nakano Y; Maeshima H; Hukatsu M; Ozawa K; Suzuki T; Arai H
    Psychiatry Res; 2014 Aug; 218(1-2):101-5. PubMed ID: 24768252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which adverse effects influence the dropout rate in selective serotonin reuptake inhibitor (SSRI) treatment? Results for 50,824 patients.
    Kostev K; Rex J; Eith T; Heilmaier C
    Ger Med Sci; 2014; 12():Doc15. PubMed ID: 25332703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spotlight on sertraline in the management of major depressive disorder in elderly patients.
    Muijsers RB; Plosker GL; Noble S
    CNS Drugs; 2002; 16(11):789-94. PubMed ID: 12383038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis.
    Strawn JR; Welge JA; Wehry AM; Keeshin B; Rynn MA
    Depress Anxiety; 2015 Mar; 32(3):149-57. PubMed ID: 25449861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.